Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Conclusion: The Future of Single-Isomer Pharmacology
1
x
$
0.00
Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies
1
x
$
30.00
Critical Analysis of Recent Phase III Studies for the Treatment of Colorectal Cancer Implications for Future Clinical Trial Design
1
x
$
10.00
Improved Efficacy of Pregabalin by Restoring Plasma Vitamin D Levels in Migraine: a Case Report
1
x
$
30.00
Takefumi Suzuki, MD, PhD: A Potentially Aborted Neuroleptic Malignant Syndrome Following Seclusion Against Uncontrollable Water Intoxication
1
x
$
30.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (Q-LES-Q-SF)
1
x
$
0.00
Metabolic Syndrome with Different Antipsychotics: A Multicentre Cross-Sectional Study
1
x
$
30.00
Neurociencias: Estudios poblacionales de la relación entre el traumatismo craneoencefálico y la psiquiatría
1
x
$
0.00
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
1
x
$
30.00
John P. Houston - Early Symptom Change Prediction of Remission in Depression Treatment
1
x
$
30.00
Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks
1
x
$
30.00
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target
1
x
$
30.00
View Cart
Checkout
Home
Store
“Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Jeffrey Alderman, PhD: The Effect of Food on the Absorption of Oral Ziprasidone
$
30.00
Add to cart
Details
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Can We Distinguish Anxiety From Depression?
$
30.00
Add to cart
Details
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
$
30.00
Add to cart
Details
Depression Treatment: A Lifelong Commitment?
$
30.00
Add to cart
Details
Mechanism of Action of Antidepressants
$
30.00
Add to cart
Details
Depression in the Elderly
$
30.00
Add to cart
Details
Coping With Somatic Comorbidities: Striving for Complete Recovery
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Generalized Anxiety Disorder: Raising the Expectations of Treatment
$
30.00
Add to cart
Details
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Recent Advances in the Neurobiology of Depression
$
30.00
Add to cart
Details
Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Comparing the Methods Used to Compare Antidepressants
$
30.00
Add to cart
Details
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Add to cart
Details
Previous
1
…
38
39
40
…
44
Next
Page load link
Go to Top
